Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer

Table 5 Summary of diagnostic performance of Oncuria™ in high-grade/low-grade and high stage/low stage bladder cancer

	Number of bladder cancer cases predicted by biomarker assay	AUC	Sensitivity (%)	Specificity (%)	NPV (%)	PPV (%)
Overall	42/45^a	0.95	0.93	0.93	0.99	0.65
Low-grade tumors	8/9	0.94	0.89	0.93	1.00	0.26
High-grade tumors	34/36	0.95	0.94	0.93	1.00	0.60
NMIBC	25/27	0.93	0.93	0.93	0.99	0.52
MIBC	15/16	0.97	0.94	0.93	1.00	0.39

NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, AUC Area under ROC curve;
^a1 missing an analyte and thus excluded

ISSN: 1479-5876